Eventually, the SGMRS, together with tumor grade, radiotherapy, 1p/19q codeletion, and IDH mutation, were identified as independent prognostic factors in glioma (p-value < 0.05, Figure 7B). This evidence concerns the gene IDH1 and central nervous system cancer.